US2015238619A1PendingUtilityA1
Polymeric carrier
Est. expiryMay 13, 2028(~1.8 yrs left)· nominal 20-yr term from priority
Inventors:Patrick S. StaytonAllan S. HoffmanAnthony ConvertineCraig L. DuvallDanielle BenoitRobert OverellPaul H. JohnsonAnna S. GallMary G. PrieveAmber E.E. PaschalCharbel DiabPriyadarsi De
C12N 15/87C12N 15/113A61K 9/1075A61P 43/00A61K 47/60A61K 31/7088A61K 47/6907C12N 2310/14C08F 293/005A61K 9/127A61K 47/58A61K 47/50C12N 2310/11A61K 48/00A61K 47/549A61K 47/48092A61K 47/488A61K 47/48176
47
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Provided herein are polymeric carriers suitable for the delivery of polynucleotides (e.g., oligonucleotides) and/or other therapeutic agents into a living cell.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A polymeric carrier comprising:
(a) a plurality of polymers that are block copolymers assembled into a polymeric carrier, the polymeric carrier comprising a core and a shell, the block copolymers having the chemical Formula I:
wherein
each of A 0 , A 1 , A 2 , A 3 and A 4 is —C—C—;
each of Y 0 and Y 1 is —C(O)O(2C-10C)alkyl-;
Y 2 is —C(O)OCH 2 CH 2 —;
Y 3 is a covalent bond;
Y 4 1 S—C(O)O(CH 2 ) 3 CH 3 ;
wherein tetravalent carbon atoms of A 0 -A 4 that are not fully substituted with R 1 -R 5 and Y 0 -Y 4 are completed with an appropriate number of hydrogen atoms;
each of R 1 , R 2 , R 3 , and R 5 is (1C-5C)alkyl;
R 4 is —CH 2 CH 2 CH 3 ;
Q 0 is a residue selected from the group consisting of polyoxylated alkyl, polyethylene glycol, and polypropylene glycol;
Q 1 is a residue selected from the group consisting of amino, alkylamino, ammonium, alkylammonium, and guanidine;
Q 2 is a dimethylamino residue;
Q 3 is a carboxyl residue;
m is 0 to less than 1.0;
n is greater than 0 to 1.0, wherein m+n=1;
p is 0.1 to 0.9;
q is 0.1 to 0.9;
r is 0 to 0.8 wherein p+q+r=1;
v is 1 to 25 kDa; and
w is 1 to 50 kDa; and
(b) at least one polynucleotide,
wherein the polynucleotide is not in the core of the polymeric carrier.
2 . The polymeric carrier of claim 1 , wherein Q 0 is a polyethylene glycol residue.
3 . The polymeric carrier of claim 1 , wherein Q 1 is an alkylamino residue.
4 . The polymeric carrier of claim 3 , wherein Q 1 is a dimethylamino residue.
5 . The polymeric carrier of claim 1 , wherein
Y 0 is —C(O)OCH 2 CH 2 —; and R 1 is —CH 3 .
6 . The polymeric carrier of claim 1 , wherein
Y 1 is —C(O)OCH 2 CH 2 —; and R 2 is —CH 3 .
7 . The polymeric carrier of claim 1 , wherein R 3 is —CH 3 .
8 . The polymeric carrier of claim 1 , wherein R 5 is —CH 3 .
9 . The polymeric carrier of claim 1 , wherein m is 0.
10 . The polymeric carrier of claim 9 , wherein Q 1 is an alkylamino residue.
11 . The polymeric carrier of claim 10 , wherein Q 1 is a dimethylamino residue.
12 . The polymeric carrier of claim 1 , wherein the polynucleotide is an oligonucleotide.
13 . The polymeric carrier of claim 12 , wherein the polynucleotide is an siRNA.
14 . The polymeric carrier of claim 1 , further comprising a targeting moiety.
15 . The polymeric carrier of claim 14 , wherein the targeting moiety is attached to the shell portion by a covalent bond to a polymer.
16 . The polymeric carrier of claim 1 , wherein the plurality of polymers have spontaneously self-assembled into the polymeric carrier.
17 . The polymeric carrier of claim 1 , wherein v is 5 to 25 kDa.
18 . The polymeric carrier of claim 1 , wherein w is 5 to 50 kDa.
19 . A composition comprising the polymeric carrier of claim 1 .
20 . A method for intracellular delivery of a polynucleotide to a cell, the method comprising contacting a cell with the polymeric carrier of claim 1 .Join the waitlist — get patent alerts
Track US2015238619A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.